# Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/trastuzumab-duocarmazine-in-locally-advanced-and-metastatic-solid-tumours-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Udai Banerji,Carla M.L. van Herpen,Cristina Saura,Fiona Thistlethwaite,Simon Lord,Víctor Moreno,Iain R. Macpherson,Valentina Boni,Christian Rolfo,Elisabeth G.E. de Vries,Sylvie Rottey,Jill J.J. Geenen,Ferry A.L.M. Eskens,Marta Gil-Martín,Ellen C.M. Mommers,N.P. Koper,Philippe Aftimos |
| Citations | 575 |
| DOI | 10.1016/s1470-2045(19)30328-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S1470204519303286/pdf |
| OpenAlex ID | https://openalex.org/W2953684910 |
| PMID | 31257177 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Philippe Aftimos](https://scholariq.org/researchers/philippe-aftimos/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.